GB9010404D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9010404D0
GB9010404D0 GB909010404A GB9010404A GB9010404D0 GB 9010404 D0 GB9010404 D0 GB 9010404D0 GB 909010404 A GB909010404 A GB 909010404A GB 9010404 A GB9010404 A GB 9010404A GB 9010404 D0 GB9010404 D0 GB 9010404D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909010404A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB909010404A priority Critical patent/GB9010404D0/en
Publication of GB9010404D0 publication Critical patent/GB9010404D0/en
Priority to EP91907827A priority patent/EP0530207A1/en
Priority to PCT/EP1991/000737 priority patent/WO1991017162A1/en
Priority to CA002078007A priority patent/CA2078007A1/en
Priority to JP3507697A priority patent/JPH05505199A/ja
Priority to PT97587A priority patent/PT97587A/pt
Priority to IE155291A priority patent/IE911552A1/en
Priority to FI925054A priority patent/FI925054A0/fi
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
GB909010404A 1990-05-09 1990-05-09 Therapeutic agents Pending GB9010404D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB909010404A GB9010404D0 (en) 1990-05-09 1990-05-09 Therapeutic agents
EP91907827A EP0530207A1 (en) 1990-05-09 1991-04-17 Imidazopyridine paf antagonists
PCT/EP1991/000737 WO1991017162A1 (en) 1990-05-09 1991-04-17 Imidazopyridine paf antagonists
CA002078007A CA2078007A1 (en) 1990-05-09 1991-04-17 Imidazopyridine paf antagonists
JP3507697A JPH05505199A (ja) 1990-05-09 1991-04-17 イミダゾピリジンｐａｆ拮抗剤
PT97587A PT97587A (pt) 1990-05-09 1991-05-07 Processo para a preparacao de antagonistas do factor de activacao de plaquetas de imidazopiridina
IE155291A IE911552A1 (en) 1990-05-09 1991-05-08 Imidazopyridine paf antagonists
FI925054A FI925054A0 (fi) 1990-05-09 1992-11-06 Imidazopyridin paf-antagonister

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909010404A GB9010404D0 (en) 1990-05-09 1990-05-09 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9010404D0 true GB9010404D0 (en) 1990-06-27

Family

ID=10675702

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909010404A Pending GB9010404D0 (en) 1990-05-09 1990-05-09 Therapeutic agents

Country Status (8)

Country Link
EP (1) EP0530207A1 (fi)
JP (1) JPH05505199A (fi)
CA (1) CA2078007A1 (fi)
FI (1) FI925054A0 (fi)
GB (1) GB9010404D0 (fi)
IE (1) IE911552A1 (fi)
PT (1) PT97587A (fi)
WO (1) WO1991017162A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200245D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
WO2001035964A1 (en) 1999-11-18 2001-05-25 Antexpharma, Inc. Substituted 1-benzazepines and derivatives thereof
US6242461B1 (en) * 2000-01-25 2001-06-05 Pfizer Inc. Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
HN2001000224A (es) * 2000-10-19 2002-06-13 Pfizer Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
TWI243164B (en) 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
US20040192728A1 (en) 2003-02-03 2004-09-30 Ellen Codd Quinoline-derived amide modulators of vanilloid VR1 receptor
US7449481B2 (en) 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
TW200538453A (en) * 2004-04-26 2005-12-01 Bristol Myers Squibb Co Bicyclic heterocycles as kinase inhibitors
CA2580852A1 (en) 2004-09-21 2006-03-30 Synta Pharmaceutical Corp. Compounds for inflammation and immune-related uses
GB0507575D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
WO2007034277A1 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists
AU2007312310A1 (en) 2006-10-16 2008-04-24 Novartis Ag Phenylacetamides useful as protein kinase inhibitors
EP2651930B1 (en) * 2010-12-16 2015-10-28 Boehringer Ingelheim International GmbH Biarylamide inhibitors of leukotriene production
CA2877474A1 (en) * 2011-06-20 2012-12-27 Myrexis, Inc. Compounds and therapeutic uses thereof
CN106632107A (zh) 2012-12-19 2017-05-10 巴斯夫欧洲公司 取代[1,2,4]三唑及其作为杀真菌剂的用途
JP7485502B2 (ja) * 2016-05-04 2024-05-16 ベ．セ．イ． ファルマ プロテインキナーゼ阻害剤としてのアデニン誘導体
CN114262322A (zh) * 2020-09-16 2022-04-01 中国科学院上海有机化学研究所 一类细胞程序性坏死抑制剂及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104933A (en) * 1987-09-30 1994-07-30 Pfizer Ltd Platelet activating factor antagonists
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8905130D0 (en) * 1989-03-07 1989-04-19 Pfizer Ltd Therapeutic agents
DE69008906T2 (de) * 1989-03-23 1994-08-25 Pfizer Antiallergische Mittel auf der Basis von Diazepin.

Also Published As

Publication number Publication date
WO1991017162A1 (en) 1991-11-14
PT97587A (pt) 1992-02-28
FI925054A (fi) 1992-11-06
EP0530207A1 (en) 1993-03-10
JPH05505199A (ja) 1993-08-05
CA2078007A1 (en) 1991-11-10
FI925054A0 (fi) 1992-11-06
IE911552A1 (en) 1991-11-20

Similar Documents

Publication Publication Date Title
GB9026389D0 (en) Therapeutic agents
GB9010404D0 (en) Therapeutic agents
GB9018139D0 (en) Therapeutic agents
GB9004260D0 (en) Therapeutic agents
GB9000725D0 (en) Therapeutic agents
GB9024345D0 (en) Therapeutic agents
GB9014061D0 (en) Therapeutic agents
GB9019833D0 (en) Therapeutic agents
GB9019409D0 (en) Therapeutic agents
GB9016655D0 (en) Therapeutic agents
GB9015524D0 (en) Therapeutic agents
GB9002423D0 (en) Therapeutic agents
GB9007837D0 (en) Therapeutic agents
GB9025385D0 (en) Therapeutic agents
GB9001018D0 (en) Therapeutic agents
GB9002318D0 (en) Therapeutic agents
GB9002424D0 (en) Therapeutic agents
GB9002425D0 (en) Therapeutic agents
GB9002426D0 (en) Therapeutic agents
GB9002427D0 (en) Therapeutic agents
GB9002428D0 (en) Therapeutic agents
GB9002429D0 (en) Therapeutic agents
GB9002317D0 (en) Therapeutic agents
GB9012165D0 (en) Therapeutic agents
GB9010791D0 (en) Therapeutic agents